Quarterly report pursuant to Section 13 or 15(d)

Inventories (Tables)

v3.21.2
Inventories (Tables)
3 Months Ended
Aug. 31, 2021
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current

(in thousands)

August 31, 2021

May 31, 2021

Raw materials

$

26,034

$

28,085

Work-in-progress

 

65,524

 

65,394

Total

$

91,558

$

93,479

Schedule of remaining shelf life of inventory

Expiration period ending August 31,

Remaining shelf-life

Raw materials

Work-in-progress bulk drug product

Work-in-progress finished drug product in vials

Total inventories

2022

0 to 12 months

$

4,547

$

-

$

-

$

4,547

2023

12 or 24 months

17,457

-

-

17,457

2024

24 to 36 months

550

-

-

550

2025

36 to 48 months

1,626

-

45,236

46,862

2026

48 to 60 months

704

-

-

704

Thereafter

60 or more months

2,977

20,288

-

23,265

Total inventories

27,861

20,288

45,236

93,385

Inventories reserved

(1,827)

-

-

(1,827)

Total inventories, net

$

26,034

$

20,288

$

45,236

$

91,558